Drugs / PBI-4547
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04068259 | Sep → Oct 2019 | — | Liminal BioSciences Ltd. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PBI-4547 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04068259 ↗ |
| Route | Oral | “Dose 1 of PBI-4547 or matching Placebo tablets by mouth” NCT04068259 ↗ |